TSS
CGTX icon

Two Sigma Securities’s Cognition Therapeutics CGTX Stock Holding History

Two Sigma Securities’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.2K Buy
31,863
+3,223
+11% +$3.75K ﹤0.01% 1348
2025
Q4 		$38.7K Buy
+28,640
New +$46.5K 0.01% 1107
2025
Q2 		– Sell
-31,750
Closed -$13.4K – 1566
2025
Q1 		$13.4K Buy
31,750
+18,009
+131% +$10.6K ﹤0.01% 1175
2024
Q4 		$9.64K Buy
+13,741
New +$6.79K ﹤0.01% 1439

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Two Sigma Securities's CGTX Position: Q1 2026 in Review

Two Sigma Securities increased its Cognition Therapeutics (CGTX) stake by 11% in Q1 2026, buying an estimated $3.75K and bringing the position to 31,863 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1348.

Two Sigma Securities first reported a position in CGTX in Q4 2024 and has held it in 4 quarters since. The position peaked at $38.7K in Q4 2025. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

  • Two Sigma Securities held 31,863 shares of Cognition Therapeutics worth $24.2K as of Q1 2026.
  • Two Sigma Securities bought 3,223 Cognition Therapeutics shares in Q1 2026, an estimated $3.75K.
  • Cognition Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1348 holding.
  • Two Sigma Securities first reported a position in Cognition Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • Two Sigma Securities's Cognition Therapeutics position peaked at $38.7K in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.